Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Gentle Tangential Flow Filtration System Safeguards Fragile Biotech Products

By LabMedica International staff writers
Posted on 15 Feb 2010
Many biotechnical processes require the separation of target molecules from a complex matrix of starting materials including growth media and cell lysates, and a new tangential flow filtration (TFF) system makes such separations easier and faster.

A separation system utilizing vibrating membrane filtration (VMF) technology and encapsulated hydrophilic polyethersulfone membrane filter modules has been introduced recently by Pall Corporation (Port Washington, NY, USA), a major producer of filtration, separation, and purification products.

The new PallSep Biotch System is recommended for the gentle separation of target molecules from complex process fluids containing high levels of biomass or particulates and high viscosity. More...
The shear forces generated by VMF are limited to a narrow layer on the membrane surface, ensuring that the bulk of the process fluid is not exposed to the shear. In addition, the required cross flow is much lower when compared to other TFF technologies. The system allows for a dynamic membrane filtration with lower energy input and gentle processing of the target molecule with a low-pressure drop.

The PallSep Biotech System consists of encapsulated 0.2-micron polyethersulfone (PES) filter modules with filter areas of 0.2, 1, and 5 square meters, which allow for process development and full-scale production.

The PallSep Biotech System employs an offset motor that induces oscillation of two masses (the membrane module and a seismic plate) connected by a torsion rod. Operation near the resonance frequency of about 50 Hz requires a very low energy input to maintain the oscillation of the two masses. The oscillation prevents particulates from accumulating at the membrane surface and thus fouling the membrane surface. A stable permeate flow is maintained while achieving high levels of product transmission, even with high particulate density and viscosity.

In order to satisfy customer-specific requirements, the PallSep Biotech System includes all the valves, pumps, sensors, vessel, and piping elements mounted on a skid assembly to operate the unit, either in manual or automated conditions.
"The new PallSep Biotech system expands processing options by allowing users to combine different process steps such as harvest and clarification within the same system, thus simplifying the process design,” said Nathalie Pathier, TFF product manager at Pall Life Sciences. "The stable permeate flow and improved protein transmission that we can achieve with this technology contributes to better process economics.”

Related Links:

Pall Corporation



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Homocysteine Quality Control
Liquichek Homocysteine Control
Alcohol Testing Device
Dräger Alcotest 7000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.